{"organizations": [], "uuid": "d708dafcde56e0926a552cae681aee0b92f0e1a8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180522.html", "section_title": "Archive News &amp; Video for Tuesday, 22 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-windtree-receives-07-mln-sbir-gran/brief-windtree-receives-0-7-mln-sbir-grant-in-continuing-support-of-the-aerosurf-phase-2b-clinical-trial-completion-idUSASC0A39S", "country": "US", "domain_rank": 408, "title": "BRIEF-Windtree Receives $0.7 Mln SBIR Grant In Continuing Support Of The Aerosurf Phase 2b Clinical Trial Completion", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.889, "site_type": "news", "published": "2018-05-23T04:55:00.000+03:00", "replies_count": 0, "uuid": "d708dafcde56e0926a552cae681aee0b92f0e1a8"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-windtree-receives-07-mln-sbir-gran/brief-windtree-receives-0-7-mln-sbir-grant-in-continuing-support-of-the-aerosurf-phase-2b-clinical-trial-completion-idUSASC0A39S", "ord_in_thread": 0, "title": "BRIEF-Windtree Receives $0.7 Mln SBIR Grant In Continuing Support Of The Aerosurf Phase 2b Clinical Trial Completion", "locations": [], "entities": {"persons": [{"name": "continu", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "windtree therapeutics inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 22 (Reuters) - Windtree Therapeutics Inc:\n* WINDTREE RECEIVES $0.7 MILLION SBIR GRANT IN CONTINUING SUPPORT OF THE AEROSURFÂ® PHASE 2B CLINICAL TRIAL COMPLETION Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-23T04:55:00.000+03:00", "crawled": "2018-05-23T15:05:10.011+03:00", "highlightTitle": ""}